Cambridge Trust Co. lowered its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 7.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 145,457 shares of the industrial products company’s stock after selling 11,358 shares during the quarter. Cambridge Trust Co.’s holdings in Xylem were worth $16,634,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in XYL. Bruce G. Allen Investments LLC purchased a new position in shares of Xylem during the 4th quarter worth approximately $27,000. Coppell Advisory Solutions LLC purchased a new position in shares of Xylem during the 2nd quarter worth approximately $45,000. KB Financial Partners LLC purchased a new position in shares of Xylem during the 1st quarter worth approximately $42,000. NBC Securities Inc. purchased a new position in shares of Xylem during the 3rd quarter worth approximately $38,000. Finally, Orion Capital Management LLC purchased a new position in shares of Xylem during the 3rd quarter worth approximately $48,000. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Price Performance
Shares of NYSE XYL traded up $0.75 on Thursday, hitting $126.97. The company’s stock had a trading volume of 510,134 shares, compared to its average volume of 1,138,997. Xylem Inc. has a 12-month low of $87.59 and a 12-month high of $130.86. The company has a market capitalization of $30.78 billion, a price-to-earnings ratio of 46.78, a price-to-earnings-growth ratio of 2.55 and a beta of 1.10. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30. The stock has a 50 day moving average of $126.85 and a 200-day moving average of $112.01.
Xylem Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date was Tuesday, February 20th. This is a positive change from Xylem’s previous quarterly dividend of $0.33. Xylem’s payout ratio is currently 52.94%.
Insider Activity
In other news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. Robert W. Baird increased their price objective on shares of Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a research report on Thursday, March 21st. Citigroup raised their price target on shares of Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Oppenheimer raised their price target on shares of Xylem from $133.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday. Stifel Nicolaus raised their price target on shares of Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. Finally, Royal Bank of Canada raised their price target on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 7th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $138.11.
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
- Five stocks we like better than Xylem
- Investing in Construction Stocks
- Comprehensive PepsiCo Stock Analysis
- What Investors Need to Know About Upcoming IPOs
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Stock Average Calculator
- 3 Steel Stocks Could Soar on New China Tariffs
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.